BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 38656525)

  • 1. Precision Genome Editing with CRISPR-Cas9.
    Rahman S; Ikram AR; Azeem F; Tahir Ul Qamar M; Shaheen T; Mehboob-Ur-Rahman
    Methods Mol Biol; 2024; 2788():355-372. PubMed ID: 38656525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.
    Tatiossian KJ; Clark RDE; Huang C; Thornton ME; Grubbs BH; Cannon PM
    Mol Ther; 2021 Mar; 29(3):1057-1069. PubMed ID: 33160457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Design of gRNA for CRISPR/Cas9-Mediated Gene Knockout.
    Freudhofmaier M; Hoyle JW; Maghuly F
    Methods Mol Biol; 2024; 2788():287-294. PubMed ID: 38656521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
    Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Microbial Modification Tools to Convert Lipids into Other Value-Added Products.
    Kumari P; Yusuf F; Gaur NA
    Methods Mol Biol; 2019; 1995():161-171. PubMed ID: 31148128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair.
    Savic N; Ringnalda FC; Lindsay H; Berk C; Bargsten K; Li Y; Neri D; Robinson MD; Ciaudo C; Hall J; Jinek M; Schwank G
    Elife; 2018 May; 7():. PubMed ID: 29809142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
    Shou J; Li J; Liu Y; Wu Q
    Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
    Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
    Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
    Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
    Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Disruption Using CRISPR-Cas9 Technology.
    Hu N; Malek SN
    Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
    Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
    Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baculovirus-based genome editing in primary cells.
    Mansouri M; Ehsaei Z; Taylor V; Berger P
    Plasmid; 2017 Mar; 90():5-9. PubMed ID: 28119062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.